Injection site reactions, including erythema, pruritus, and nodule formation (particularly with extended-release formulations), occur in approximately 10-20% of patients
Lexapro, a selective serotonin reuptake inhibitor, targets depression and anxiety , while Wegovy, a GLP-1 receptor agonist, focuses on weight loss and blood sugar regulation
While insurance coverage can ameliorate the cost for some, insurance companies have increased the requirements for individuals to receive prior authorization for these medications or are dropping coverage altogether
check the NIHR 'Be Part of Research' portal or ClinicalTrials.gov for current recruiting studies
Note: Ozempic , Mounjaro , Victoza , and metformin are not FDA-approved to treat obesity or for weight loss
2023;15:e41407